homoopathie-globuli-naturopathy-naturopaths-homeopathy-beads-royalty-free-thumbnail

World’s second largest API company to be created by Sanofi

pharmafile | February 25, 2020 | News story | Manufacturing and Production API, APIs, China API, Coronavirus API, India API, Sanofi 

Sanofi plans to create a new company in Europe dedicated to the production and marketing of active pharmaceutical ingredients (API).

This news comes amidst the coronavirus outbreak, which is threatening the global drug production line due to many countries importing APIs from China.

This new entity will help balance Europe’s reliance on these Chinese and Indian API imports. It would consist of Sanofi combining its European API production sites in Italy, Germany, the UK, Hungary and two others in France. When created, it would rank as the second largest API company in the world with a predicted $1 billion in sales by 2022. Sanofi would hold a 30% stake in the new company and intends it to be debt free to maximise its investment capacities.

Commenting on the plans, Philippe Luscan, Executive Vice President, Global Industrial Affairs at Sanofi, said: “Based on the expertise and experience built over decades within our industrial network, this new entity would help ensure a greater stability in supplying drugs to millions of patients in Europe and beyond. With this endeavour, this new entity would be agile as a standalone company, and able to unlock its growth potential, especially in capturing new third-party sales and all the opportunities of a market growing at a pace of 6% per year.”

Conor Kavanagh

 

Related Content

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

Sanofi has announced positive results from its phase 3 LUNA 3 study, which assessed rilzabrutinib …

Sanofi shares phase 2b results for dermatitis treatment

Sanofi has shared positive results from part 2 of the investigational phase 2b STREAM-AD study …

Sanofi to acquire Inhibrx for approximately $1.7bn

Sanofi and Inhibrx, Inc have announced that they have entered into a definitive agreement for …

Latest content